How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,785 results for

Mycosis Fungoides

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

163. Risk Factors for Skin Infections in Mycosis Fungoides. Full Text available with Trip Pro

Risk Factors for Skin Infections in Mycosis Fungoides. Mycosis fungoides (MF) is the most frequent type of primary cutaneous natural killer and T-cell lymphoma. MF-required immunosuppressive therapies and MF-related immunosuppressive characteristics render patients with MF more prone to infections.To describe the clinical features of cutaneous infections observed in MF patients.A series of 56 MF patients were followed prospectively over 3 years and screened for cutaneous infections.Prospective

2017 Dermatology

164. Unilesional plantar mycosis fungoides treated with topical photodynamic therapy - case report and review of the literature. (Abstract)

Unilesional plantar mycosis fungoides treated with topical photodynamic therapy - case report and review of the literature. Unilesional mycosis fungoides (UMF) and pagetoid reticulosis (PR) are variants of mycosis fungoides. Conventional therapy comprises surgical excision or radiotherapy, which may be associated with long-term side effects, especially when the lesion is located at a special site like the palms and soles. Therefore, alternative treatment options are needed to treat solitary

2017 Journal of the European Academy of Dermatology and Venereology

165. Telangiectatic Mycosis Fungoides: A New Clinicopathological Presentation Mimicking Acquired Naevoid Telangiectasia. Full Text available with Trip Pro

Telangiectatic Mycosis Fungoides: A New Clinicopathological Presentation Mimicking Acquired Naevoid Telangiectasia. 28093597 2018 04 17 2018 04 17 1651-2057 97 5 2017 05 08 Acta dermato-venereologica Acta Derm. Venereol. Telangiectatic Mycosis Fungoides: A New Clinicopathological Presentation Mimicking Acquired Naevoid Telangiectasia. 651-652 10.2340/00015555-2613 García-Colmenero Lidia L Department of Dermatology, Hospital del Mar. Parc de Salut Mar., Passeig Marítim 25-29, ES-08003 Barcelona (...) , Spain. lidia.garcia.colmenero@gmail.com. Curto-Barredo Laia L Gómez-Martin Ignacio I Gallardo Fernando F Pujol Ramon M RM eng Case Reports Journal Article Sweden Acta Derm Venereol 0370310 0001-5555 IM Diagnosis, Differential Humans Male Middle Aged Mycosis Fungoides complications diagnosis pathology Skin Neoplasms complications diagnosis pathology Telangiectasis complications diagnosis 2017 1 18 6 0 2018 4 18 6 0 2017 1 18 6 0 ppublish 28093597 10.2340/00015555-2613

2017 Acta Dermato-Venereologica

166. Maintenance phase in PUVA phototherapy of early stage mycosis fungoides. A critically appraised topic. (Abstract)

Maintenance phase in PUVA phototherapy of early stage mycosis fungoides. A critically appraised topic. A 65-year-old patient affected by mycosis fungoides (MF) stage IB achieved complete remission (CR) after a cycle of PUVA phototherapy. The U.S. Cutaneous Lymphoma Consortium (USCLC) guidelines suggest that the patient should be kept in the maintenance phase, defined as a 'period of gradual decrease of frequency of UVL [ultraviolet light] while in clinical remission before discontinuation (...) PUVA phototherapy. Embase, PubMed and TRIP databases were searched for 'mycosis fungoides' AND [('photochemotherapy' OR 'puva') OR 'psoralen'] in June 2016. Three articles matched our inclusion criteria and are discussed in this CAT. In this field of research the literature is poor and the reported level of evidence is low. Only one of the studies was conducted prospectively, and none were randomized. No significant difference in terms of reduction in relapse rate or increase in RFI in patients who

2017 British Journal of Dermatology

167. Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series. (Abstract)

Complete resolution of mycosis fungoides tumors with imiquimod 5% cream: a case series. To demonstrate the clinical efficacy of topical 5% imiquimod for mycosis fungoides (MF) tumors.Treatment of tumor-stage MF represents a therapeutic challenge because of a limited number of effective topical therapies. Single tumors can be treated with localized radiation but may recur. Systemic therapies are also an option but are associated with serious adverse effects. Imiquimod is a topical agent whose

2017 Journal of Dermatological Treatment

168. CD8<sup>+</sup> mycosis fungoides: A low-grade lymphoproliferative disorder. (Abstract)

CD8+ mycosis fungoides: A low-grade lymphoproliferative disorder. The prognosis of the CD8+ subtype of mycosis fungoides (MF) is controversial. Although most authors believe that determining the presence of this cell surface antigen has no prognostic value, others have observed a more indolent course for CD8+ MF compared with CD4+ MF.To review the cases of CD8+ MF in the pediatric and adult populations seen at our institution.This is a retrospective review of clinical and pathologic

2017 Journal of American Academy of Dermatology

169. Racial disparity in mycosis fungoides: An analysis of 4495 cases from the US National Cancer Database. (Abstract)

Racial disparity in mycosis fungoides: An analysis of 4495 cases from the US National Cancer Database. Studies have shown contradictory results regarding the survival outcomes among white, African American, and Asian patients with mycosis fungoides (MF).To evaluate the survival outcomes among white, African American, and Asian patients with MF and to determine other prognostic factors of the disease.The US National Cancer Database was used to identify patients with histologically confirmed MF

2017 Journal of American Academy of Dermatology

170. Multiple skin cancers in patients with mycosis fungoides after long-term ultraviolet phototherapy. (Abstract)

Multiple skin cancers in patients with mycosis fungoides after long-term ultraviolet phototherapy. Phototherapy is a useful noninvasive therapy, but it can induce cutaneous malignant tumours, including squamous cell carcinoma (SCC) and basal cell carcinoma (BCC). We report on a 79-year-old man who had long-standing mycosis fungoides for 40 years, which had been treated with psoralen ultraviolet A therapy for 37 years at a dose of approximately 5000 J/cm2 . Approximately 6 years before

2017 Clinical & Experimental Dermatology

171. Folliculotropic Mycosis Fungoides with Skewed T-cell Receptor CDR3 motif: Suggestive of Lipid Antigen-selection? Full Text available with Trip Pro

Folliculotropic Mycosis Fungoides with Skewed T-cell Receptor CDR3 motif: Suggestive of Lipid Antigen-selection? Folliculotropic mycosis fungoides (FMF), a variant of mycosis fungoides (MF) with distinct clinical features, is characterized by infiltration of malignant T cells in hair follicles. This raises the hypothesis that antigens in the hair follicle may contribute to the pathogenesis of FMF. T-cell receptor β gene (TRB) sequences as well as dendritic cell subsets in patients with FMF (n

2017 Acta Dermato-Venereologica

172. Tumor-stage mycosis fungoides regressing with milia and pustules after total skin electron beam therapy. (Abstract)

Tumor-stage mycosis fungoides regressing with milia and pustules after total skin electron beam therapy. 28557155 2017 10 23 1468-3083 31 10 2017 Oct Journal of the European Academy of Dermatology and Venereology : JEADV J Eur Acad Dermatol Venereol Tumour-stage mycosis fungoides regressing with milia and pustules after total skin electron beam therapy. e440 10.1111/jdv.14372 Puiu T T University of Michigan Medical School, Ann Arbor, 48103, MI, USA. Porto D A DA Department of Dermatology, Henry

2017 Journal of the European Academy of Dermatology and Venereology

173. Psoriasis in patients with Mycosis Fungoides: Α clinicopathological study of 25 patients. (Abstract)

Psoriasis in patients with Mycosis Fungoides: Α clinicopathological study of 25 patients. It has been reported that patients with psoriasis are at increased risk for developing lymphoma including cutaneous T-cell lymphomas (CTCL). However, the comorbidity and the histopathologic correlation of psoriasis and mycosis fungoides (MF) have been less studied.The objective of this study was to investigate the relation between MF and psoriasis.We retrospectively reviewed and re-evaluated all MF cases

2017 Journal of the European Academy of Dermatology and Venereology

174. The role of macrophages in the pathogenesis of mycosis fungoides. (Abstract)

The role of macrophages in the pathogenesis of mycosis fungoides. Macrophages are classified into classically activated (M1) and alternatively activated (M2) macrophages. Decrease in macrophage number in tumour tissue with treatment has been reported.The aim of this study was to determine whether treatment has an effect on the number of dermal M1 and M2 macrophages in patients with mycosis fungoides (MF).In total, 21 patients (8 women, 13 men; age range 42-73 years) were included in this study

2017 Clinical & Experimental Dermatology

175. Ultraviolet A1 Phototherapy in the Treatment of Early Mycosis Fungoides. Full Text available with Trip Pro

Ultraviolet A1 Phototherapy in the Treatment of Early Mycosis Fungoides. Phototherapy has been the mainstay of therapies for early mycosis fungoides (MF). The beneficial role of ultraviolet (UV) light on MF is suggested by the observation that lesions occur on non-sun-exposed areas. Therapeutic light sources that are available today are broadband UVB, psoralen and UVA, narrowband UVB, and long-wave UV (UVA1). Current literature provides increasing evidence on the use of UVA1 to treat MF.To

2017 Dermatology

176. Concomitant Mycosis Fungoides and Vitiligo: How Mycosis Fungoides May Contribute to Melanocyte Destruction. (Abstract)

Concomitant Mycosis Fungoides and Vitiligo: How Mycosis Fungoides May Contribute to Melanocyte Destruction. Few reports have described vitiligo developing in patients with cutaneous T-cell lymphoma (CTCL).We sought to identify possible factors that might predispose patients with CTCL to vitiligo.Patient demographics, CTCL disease characteristics and treatments were analyzed in 25 patients with CTCL who developed vitiligo. Cox proportional hazards modeling was used to identify associations (...) of risk factors with the development of vitiligo.Younger age, later CTCL disease stage (stages IIB-IV) and presence of a CD8+CD4- mycosis fungoides phenotype were associated with the development of vitiligo. After adjusting for disease stage, increased risk of vitiligo was associated with methotrexate and CD4 antibody therapies (although the total number of patients with these was small), while decreased risk was associated with nitrogen mustard and PUVA therapies.No single feature was common to all

2015 Dermatology

177. Follicular Mycosis Fungoides (FMF): Meta-analysis of improved survival

Follicular Mycosis Fungoides (FMF): Meta-analysis of improved survival Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne") for correspondence: Organisation web address: Timing and effect

2018 PROSPERO

178. Mycosis Fungoides

Mycosis Fungoides Mycosis Fungoides Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Mycosis Fungoides Mycosis Fungoides Aka: Mycosis (...) Associated with superficial and deep Associated with metastases to , lung, GI tract VI. Complications VII. Course Survival <3 years after tumors develop VIII. References Habif (1996) Clinical Dermatology, Mosby, p. 674-5 Images: Related links to external sites (from Bing) These images are a random sampling from a Bing search on the term "Mycosis Fungoides." Click on the image (or right click) to open the source website in a new browser window. Related Studies (from Trip Database) Ontology: Mycosis

2018 FP Notebook

179. Psoralen ultraviolet A versus narrowband ultraviolet B phototherapy for early-stage mycosis fungoides: a systematic review and meta-analysis

Psoralen ultraviolet A versus narrowband ultraviolet B phototherapy for early-stage mycosis fungoides: a systematic review and meta-analysis Print | PDF PROSPERO This information has been provided by the named contact for this review. CRD has accepted this information in good faith and registered the review in PROSPERO. CRD bears no responsibility or liability for the content of this registration record, any associated files or external websites. Email salutation (e.g. "Dr Smith" or "Joanne

2018 PROSPERO

180. Mycosis Fungoides and the Sézary Syndrome Treatment (PDQ®): Patient Version

Mycosis Fungoides and the Sézary Syndrome Treatment (PDQ®): Patient Version Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf Warning: The NCBI web site requires JavaScript to function. Search database Search term Search NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health. PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2002-. PDQ Cancer (...) Information Summaries [Internet]. Bethesda (MD): ; 2002-. Search term Mycosis Fungoides (Including Sézary Syndrome) Treatment (PDQ®) Patient Version PDQ Adult Treatment Editorial Board . Published online: April 8, 2020. This PDQ cancer information summary has current information about the treatment of mycosis fungoides (including Sézary Syndrome). It is meant to inform and help patients, families, and caregivers. It does not give formal guidelines or recommendations for making decisions about health care

2016 PDQ - NCI's Comprehensive Cancer Database

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>